Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LivaNova PLC - Ordinary Shares (NQ:LIVN)

37.15 +0.82 (+2.26%)
Streaming Delayed Price Updated: 3:05 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 Next >
LivaNova Reports Third-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
From LivaNova PLC
Via Business Wire
LivaNova Board Appoints J. Christopher Barry as New Director
From LivaNova PLC
Via Business Wire
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
From LivaNova PLC
Via Business Wire
LivaNova to Announce Third-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Baird Global Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Reports Second-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
From LivaNova PLC
Via Business Wire
LivaNova Reports First-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Board of Directors Announce Leadership Changes
From LivaNova PLC
Via Business Wire
LivaNova to Announce First-Quarter 2023 Results
From LivaNova PLC
Via Business Wire
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova Launches SenTiva DUO
From LivaNova PLC
Via Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
From LivaNova PLC
Via Business Wire
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
From LivaNova PLC
Via Business Wire
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
From LivaNova PLC
Via Business Wire
LivaNova Reports Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Board Appoints Brooke Story as a New Director
From LivaNova PLC
Via Business Wire
LivaNova Reports Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Elects Peter Wilver to Board of Directors
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
From LivaNova PLC
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.